DR. ADITI KUMAR NPI 1497061915

NPI Details

DR. Aditi Kumar is an endocrinology and diabetes and metabolism internal medicine in Scottsdale, AZ with 17 years of experience. The provider is an internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems. DR. Aditi Kumar NPI is 1497061915. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

13400 E SHEA BLVD
SCOTTSDALE, AZ
ZIP 85259-452
Phone: (480) 301-8000

The NPI 1497061915 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, vedolizumab, 1 mg (HCPCS:J3380)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Collection of blood sample from implanted device (HCPCS:36591)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Telephone or internet assessment with written report by consulting physician, 5 minutes or more (HCPCS:99451)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)

The enumeration date for this NPI number is 8/20/2010 and was last updated on 1/25/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.